Optimization of Plerixafor Utilization Based on Peripheral Blood CD34+Count for Autologous Peripheral Blood Stem-Cell Collection

被引：0
|
作者：
Gupta, Gaurav K.
Perreault, Sera
Seropian, Stuart
Tormey, Christopher A.
Hendrickson, Jeanne E.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140171
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Optimization of repeat plerixafor dosing for autologous peripheral blood stem-cell collection
    Gupta, Gaurav K.
    Perreault, Sarah
    Seropian, Stuart E.
    Tormey, Christopher A.
    Hendrickson, Jeanne E.
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (03)
  • [2] CLINICAL USE OF PERIPHERAL BLOOD CD34+CELL COUNT AND MIDPOINT COLLECTION CD34+CELL YIELD FOR PERIPHERAL BLOOD STEM CELL COLLECTIONS FROM AUTOLOGOUS PATIENTS MOBILIZED BY G-CSF AND PLERIXAFOR
    Chepovetsky, J.
    Choo, Y. S.
    Blouin, A.
    Tindle, S.
    Bertinelli, A.
    Nash, E. M.
    Wu, D. W.
    [J]. VOX SANGUINIS, 2013, 105 : 293 - 294
  • [3] Peripheral blood CD34+ count predicts the adequacy of stem cell collection for autologous transplants.
    Ballester, OF
    Wilcox, P
    Hill, C
    Payne, M
    Tan, B
    Williams, S
    Sanchez, R
    [J]. BLOOD, 1998, 92 (10) : 296B - 297B
  • [4] Peripheral blood CD34+ cell count as a predictor of adequacy of hematopoietic stem cell collection for autologous transplantation
    Combariza, Juan F.
    Barco, Gloria
    Estrada, Angela
    Jaramillo, Sergio
    Arango, Marcos
    [J]. IATREIA, 2016, 29 (04) : 424 - 432
  • [5] UTILIZING PERIPHERAL BLOOD CD34 COUNT AS A PREDICTOR FOR THE NEED FOR PLERIXAFOR IN AUTOLOGOUS STEM CELL MOBILIZATION - SINGLE INSTITUTION EXPERIENCE
    Abusin, G. A.
    Abu-Arja, R. F.
    Gingrich, R. D.
    Schlueter, A. J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S200 - S200
  • [6] Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma
    Shah, Eshana E.
    Young, Rebecca P.
    Wong, Sandy W.
    Damon, Lloyd E.
    Wolf, Jeffrey L.
    Shah, Nina D.
    Leavitt, Andrew D.
    Loeffler, Paula
    Martin, Thomas G.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (05) : 876 - 883
  • [7] Impact of Plerixafor Use at Different Peripheral Blood CD34+Cell Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma
    Shah, Eshana E.
    Young, Rebecca
    Wong, Sandy W.
    Martin, Thomas G.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S150 - S151
  • [8] CD34+ Collection Efficiency as a Function of Blood Volumes Processed in Pediatric Autologous Peripheral Blood Stem Cell Collection
    Dubrovsky, Leonid
    Wong, Edward C. C.
    Perez-Albuerne, Evelio
    Loechelt, Brett
    Kamani, Naynesh
    Sande, Jane
    Mintz, Kathy
    Paul, Wendy
    Luban, Naomi L. C.
    Rood, Brian R.
    Fry, Terry
    [J]. JOURNAL OF CLINICAL APHERESIS, 2011, 26 (03) : 131 - 137
  • [9] An algorithm for utilizing peripheral blood CD34 count as a predictor of the need for plerixafor in autologous stem cell mobilizationcost-effectiveness analysis
    Abusin, Ghada A.
    Abu-Arja, Rolla F.
    Gingrich, Roger D.
    Silverman, Margarida D.
    Zamba, Gideon K. D.
    Schlueter, Annette J.
    [J]. JOURNAL OF CLINICAL APHERESIS, 2013, 28 (04) : 293 - 300
  • [10] Impact of CD34+pre-counting and plerixafor on autologous peripheral blood stem cell collection in Japanese university hospitals in eight years
    Nakamura, Yuki
    Okubo, Mitsuo
    Furuta, Yoshiaki
    Tokida, Miho
    Ichikawa, Kayoko
    Ohsaka, Akimichi
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2019, 58 (06)
12345